Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$279,969
-$8,151 QoQ
Shares Held
5,840
-25.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#920
of 1,348 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GFS Advisors, LLC holds $987,567 across 10 Drug Manufacturers - General names. NVO ranks #2 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
300 | $359,829 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
5,840 | $279,969 | |
| 3 | JNJ |
Johnson & Johnson
|
46,182 | $143,960 | |
| 4 | ABBV |
AbbVie Inc.
|
10,263 | $143,938 | |
| 5 | GSK |
GSK plc
|
372 | $19,500 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,710 | $18,634 | |
| 7 | OGN |
Organon & Co.
|
1,267 | $17,155 | |
| 8 | MRK |
Merck & Co., Inc.
|
79,011 | $3,361 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,969 | 5,840 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $288,120 | 7,840 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $286,200 | 5,625 | Shares | Sole | 2026-02-11 | |
| 2024-12-31 | $239,651 | 2,786 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||